When delays and disruptions threaten not only product integrity but patient well-being, thorough risk assessment and mitigation are essential.

Growth through acquisition has been an attractive option for many organizations in the pharma cold chain. One recent example is Knipper Health, long known for its marketing services and 3PL operations ...